Hosted by the DNB//Back Bay Healthcare Partnership, the NAHC unites large and mid-cap public and private IPO-ready US and Nordic life science companies. Participating companies showcase leading products that offer substantial advancements in patient care, making them highly appealing investment opportunities.
Read MoreDNB//Back Bay is pleased to sponsor the BIO International Convention, the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.
Read MoreThis two-day equity conference is by invitation to institutional healthcare specialist and generalist investors, industry experts, corporate development, and healthcare executives. The NAHC includes sector-specific panel discussions with insights from DNB healthcare equity analysts, industry leaders, and investors.
Read More
